Benefits
Low osmolality, but stomach emptying was never measured in the cited studies
Low osmolality is a measurable property of HBCD, and the theory is that a low osmolality drink leaves the stomach faster and causes less bloating, cramping and reflux than a concentrated sugar drink. None of the studies cited on this page measured gastric emptying or digestive symptoms in people, so this remains an idea about how the ingredient might work rather than a tested result.
Steady energy with little insulin response: shown in mice, not confirmed in people
The idea of a steady glucose rise with little insulin response comes largely from a 1999 study in mice, not from people. In the human endurance study cited here, blood glucose patterns were similar whether participants drank HBCD or maltodextrin, and no cited human study measured insulin levels or reactive hypoglycemia. Athletes do use HBCD drinks for this reason, but the human evidence for it is not on this page.
Lower perceived exertion in endurance work
This is the best supported claim on the page. In a 2014 crossover study, 15 g of HBCD taken during endurance exercise produced a smaller rise in rating of perceived exertion, meaning how hard the effort felt, at 30 and 60 minutes than maltodextrin did. Two limits matter: perceived exertion is a feeling, not work performed, and the trial reported no improvement in speed, power or output. The published abstract also does not state how many people took part.
Hydration and fluid absorption have not been tested
How fast the stomach empties is one of the steps that limits fluid absorption during exercise, which is why low osmolality drinks are of interest to sports nutrition companies. No study cited on this page measured hydration, fluid absorption or stomach emptying in people, so there is no evidence here that Cluster Dextrin hydrates an athlete better than any other carbohydrate drink.
No combat sport or stomach tolerance studies are cited here
Athletes in combat sports often find ordinary carbohydrate drinks hard to stomach before competition, and HBCD is marketed as an easier option. None of the studies cited on this page involved combat sport athletes, and none recorded nausea or other stomach symptoms, so this is a marketing position rather than a research finding.
Mechanism of action
Low osmolality enables rapid gastric emptying
HBCD's narrow molecular weight distribution around ~160 kDa yields very low osmolality (<10 mOsm) compared with maltodextrin or glucose. In general, solutions with higher osmolality leave the stomach more slowly, so a low osmolality drink would be expected to empty faster. This has not been measured for HBCD in any study cited on this page.
Branching enzyme cyclic glucan architecture
Produced by treating waxy maize starch with a branching enzyme, HBCD forms a highly branched cyclic structure with alpha-1,4 and alpha-1,6 linkages. This compact branched cluster is thought to resist rapid breakdown by digestive enzymes at its surface while still being fully digestible, which is the proposed reason for a slower, steadier glucose release.
Proposed steadier glucose and insulin response
The proposed mechanism is that HBCD is absorbed more gradually than maltodextrin, giving flatter blood glucose and insulin curves. The main support for this is the 1999 mouse study. In the human endurance study cited here, blood glucose responses were similar for HBCD and maltodextrin, and no cited human study measured insulin, muscle glycogen use or rebound hypoglycemia.
Reduced gut osmotic load
Conventional sport-drink carbohydrates draw water into the intestinal lumen via osmotic gradients, contributing to bloating and diarrhea during exercise. HBCD's low osmolality would be expected to reduce this osmotic shift. The studies cited on this page did not record digestive symptoms, so any reduction in gut distress is untested here.
Clinical trials
Crossover trial (PMID 25080121, Biosci Biotechnol Biochem 2014) comparing a drink containing 15 g of highly branched cyclic dextrin against maltodextrin during prolonged endurance exercise. The main outcome was rating of perceived exertion, meaning how hard the exercise felt, alongside blood markers of energy metabolism. The published abstract does not state how many people took part.
Endurance-trained participants in a crossover design. The number of participants is not stated in the published abstract.
Ratings of perceived exertion rose significantly less at 30 and 60 minutes after HBCD than after maltodextrin, while blood glucose patterns were comparable between the two drinks. This is a perception result only. The trial did not report any improvement in speed, power or work completed, and the number of participants was not reported.
Small trial in seven male triathletes (PMID 25270782, J Sports Med Phys Fitness 2014) comparing a sports drink based on highly branched cyclic dextrin against a control drink during exhaustive endurance exercise. The outcomes were white blood cell counts and cytokines measured in blood and urine, which are laboratory markers of immune and inflammatory stress, not measures of performance.
Seven male triathletes. With only seven people, chance findings cannot be ruled out.
Mostly no difference. Lymphocyte and neutrophil counts and the blood cytokines IL-8 and IL-10 rose to a similar degree with both drinks, with no significant difference between them. Only cytokines measured in urine after the race were lower with HBCD. These are laboratory markers in seven people, and nothing in this study showed better performance or faster recovery.
Randomized, double-blind, placebo-controlled crossover trial in 30 people (PMID 39644922, Clin Nutr ESPEN 2025) testing 45 g of highly branched cyclic dextrin taken during a resistance training session. Outcomes were repetitions completed, movement velocity, blood lactate and perceived fatigue.
30 resistance-trained men and women completing a standardized resistance training protocol.
Largely negative. Repetitions completed were not significantly different from placebo, perceived fatigue was unchanged, and blood lactate with HBCD was comparable or higher than with placebo. Movement velocity improved in the men but not in the women. A sex-specific result in 30 people is a preliminary signal that needs to be repeated, and the study does not support HBCD as a performance aid for resistance training.